This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jun 7;295(21):2477; author reply 2478-9.

doi: 10.1001/jama.295.21.2477-a.

High-dose statins and the IDEAL study

Paul S Chan, Brahmajee K Nallamothu, Rodney A Hayward

PMID: 16757716
DOI: 10.1001/jama.295.21.2477-a

Comment

High-dose statins and the IDEAL study

Paul S Chan et al. JAMA. 2006.

. 2006 Jun 7;295(21):2477; author reply 2478-9.

doi: 10.1001/jama.295.21.2477-a.

Authors

Paul S Chan, Brahmajee K Nallamothu, Rodney A Hayward

PMID: 16757716
DOI: 10.1001/jama.295.21.2477-a

No abstract available

PubMed Disclaimer

Comment on

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J; Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. Pedersen TR, et al. JAMA. 2005 Nov 16;294(19):2437-45. doi: 10.1001/jama.294.19.2437. JAMA. 2005. PMID: 16287954 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information